Journal of Market Access & Health Policy
Volume 5, 2017 - Issue 1
Open access
2,031
Views
27
CrossRef citations to date
0
Altmetric
ARTICLE
Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
Zoltán KalóDepartment of Health Policy and Health Economics, Eötvös Loránd University, Budapest, HungaryView further author information
, Zoltán VokóDepartment of Health Policy and Health Economics, Eötvös Loránd University, Budapest, HungaryView further author information
, Andrew ÖstörRheumatology Clinical Research Unit, Addenbrookes Hospital, Cambridge, UKView further author information
, Emma Clifton-BrownGlobal Health & Value, Pfizer Ltd, Tadworth, UKView further author information
, Radu VasilescuGlobal Health & Value, Pfizer Ltd, Tadworth, UKView further author information
, Alysia BattersbyWickenstones, Oxfordshire, UKView further author information
& Edward GibsonWickenstones, Oxfordshire, UKCorrespondence[email protected]
View further author information
show allView further author information
Article: 1345580
|
Received 17 Mar 2017, Accepted 19 Jun 2017, Published online: 05 Jul 2017
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.